Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma

Hyunsoo Kim, Sun Ho Lee, Sung Im Do, Sung Jig Lim, Yong Koo Park, Youn Wha Kim

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Beclin-1 has emerged as an autophagy gene in a variety of human carcinomas. The aim of this study was to evaluate beclin-1 expression and to determine its prognostic significance in patients with pancreatic ductal adenocarcinoma (PDA).We performed immunohistochemical staining for beclin-1 in 63 cases of PDA. We investigated whether beclin-1 expression correlated with clinicopathologic characteristics and patient outcomes. Beclin-1 expression was absent in normal pancreatic islet cells, acinar cells, and ductal epithelial cells. In contrast, in PDA, beclin-1 showed positive immunoreactivity in 14 of 63 (22.2%) PDA cases, while the remaining 49 (77.8%) PDA cases exhibited negative beclin-1 expression. We found significant associations between increased beclin-1 expression and the absence of lymphatic invasion (P = 0.032) and low rate of distant metastasis (P = 0.001). Univariate analysis of survival showed that the median distant metastasis-free survival of beclin-1-negative PDA patients (10 months) was significantly shorter than that of beclin-1-positive PDA patients (21 months; P = 0.031).Our results suggest that increased beclin-1 expression plays a role in the inhibition of PDA progression.

Original languageEnglish
Pages (from-to)247-252
Number of pages6
JournalPathology Research and Practice
Volume207
Issue number4
DOIs
Publication statusPublished - 2011 Apr 15

Fingerprint

Adenocarcinoma
Islets of Langerhans
Beclin-1
Neoplasm Metastasis
Acinar Cells
Autophagy
Survival Analysis
Epithelial Cells
Staining and Labeling
Carcinoma
Survival
Genes

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Kim, Hyunsoo ; Lee, Sun Ho ; Do, Sung Im ; Lim, Sung Jig ; Park, Yong Koo ; Kim, Youn Wha. / Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma. In: Pathology Research and Practice. 2011 ; Vol. 207, No. 4. pp. 247-252.
@article{ea35ef3265d44775ac854cceb5a20b91,
title = "Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma",
abstract = "Beclin-1 has emerged as an autophagy gene in a variety of human carcinomas. The aim of this study was to evaluate beclin-1 expression and to determine its prognostic significance in patients with pancreatic ductal adenocarcinoma (PDA).We performed immunohistochemical staining for beclin-1 in 63 cases of PDA. We investigated whether beclin-1 expression correlated with clinicopathologic characteristics and patient outcomes. Beclin-1 expression was absent in normal pancreatic islet cells, acinar cells, and ductal epithelial cells. In contrast, in PDA, beclin-1 showed positive immunoreactivity in 14 of 63 (22.2{\%}) PDA cases, while the remaining 49 (77.8{\%}) PDA cases exhibited negative beclin-1 expression. We found significant associations between increased beclin-1 expression and the absence of lymphatic invasion (P = 0.032) and low rate of distant metastasis (P = 0.001). Univariate analysis of survival showed that the median distant metastasis-free survival of beclin-1-negative PDA patients (10 months) was significantly shorter than that of beclin-1-positive PDA patients (21 months; P = 0.031).Our results suggest that increased beclin-1 expression plays a role in the inhibition of PDA progression.",
author = "Hyunsoo Kim and Lee, {Sun Ho} and Do, {Sung Im} and Lim, {Sung Jig} and Park, {Yong Koo} and Kim, {Youn Wha}",
year = "2011",
month = "4",
day = "15",
doi = "10.1016/j.prp.2011.02.007",
language = "English",
volume = "207",
pages = "247--252",
journal = "Pathology Research and Practice",
issn = "0344-0338",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "4",

}

Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma. / Kim, Hyunsoo; Lee, Sun Ho; Do, Sung Im; Lim, Sung Jig; Park, Yong Koo; Kim, Youn Wha.

In: Pathology Research and Practice, Vol. 207, No. 4, 15.04.2011, p. 247-252.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma

AU - Kim, Hyunsoo

AU - Lee, Sun Ho

AU - Do, Sung Im

AU - Lim, Sung Jig

AU - Park, Yong Koo

AU - Kim, Youn Wha

PY - 2011/4/15

Y1 - 2011/4/15

N2 - Beclin-1 has emerged as an autophagy gene in a variety of human carcinomas. The aim of this study was to evaluate beclin-1 expression and to determine its prognostic significance in patients with pancreatic ductal adenocarcinoma (PDA).We performed immunohistochemical staining for beclin-1 in 63 cases of PDA. We investigated whether beclin-1 expression correlated with clinicopathologic characteristics and patient outcomes. Beclin-1 expression was absent in normal pancreatic islet cells, acinar cells, and ductal epithelial cells. In contrast, in PDA, beclin-1 showed positive immunoreactivity in 14 of 63 (22.2%) PDA cases, while the remaining 49 (77.8%) PDA cases exhibited negative beclin-1 expression. We found significant associations between increased beclin-1 expression and the absence of lymphatic invasion (P = 0.032) and low rate of distant metastasis (P = 0.001). Univariate analysis of survival showed that the median distant metastasis-free survival of beclin-1-negative PDA patients (10 months) was significantly shorter than that of beclin-1-positive PDA patients (21 months; P = 0.031).Our results suggest that increased beclin-1 expression plays a role in the inhibition of PDA progression.

AB - Beclin-1 has emerged as an autophagy gene in a variety of human carcinomas. The aim of this study was to evaluate beclin-1 expression and to determine its prognostic significance in patients with pancreatic ductal adenocarcinoma (PDA).We performed immunohistochemical staining for beclin-1 in 63 cases of PDA. We investigated whether beclin-1 expression correlated with clinicopathologic characteristics and patient outcomes. Beclin-1 expression was absent in normal pancreatic islet cells, acinar cells, and ductal epithelial cells. In contrast, in PDA, beclin-1 showed positive immunoreactivity in 14 of 63 (22.2%) PDA cases, while the remaining 49 (77.8%) PDA cases exhibited negative beclin-1 expression. We found significant associations between increased beclin-1 expression and the absence of lymphatic invasion (P = 0.032) and low rate of distant metastasis (P = 0.001). Univariate analysis of survival showed that the median distant metastasis-free survival of beclin-1-negative PDA patients (10 months) was significantly shorter than that of beclin-1-positive PDA patients (21 months; P = 0.031).Our results suggest that increased beclin-1 expression plays a role in the inhibition of PDA progression.

UR - http://www.scopus.com/inward/record.url?scp=79955166274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955166274&partnerID=8YFLogxK

U2 - 10.1016/j.prp.2011.02.007

DO - 10.1016/j.prp.2011.02.007

M3 - Article

VL - 207

SP - 247

EP - 252

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 4

ER -